Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Morbidity and Mortality Weekly Reports

CDC’s Morbidity and Mortality Weekly Report publishes public health information and recommendations on a variety of diseases and topics. Read the most recent MMWRs on HIV.

MMWR Search

With this form, you can search through all the Morbidity and Mortality Weekly Reports:

Recent HIV-Related Reports

  • HIV Care Outcomes Among Men Who Have Sex With Men With Diagnosed HIV Infection — United States, 2015
    In 2015, 19% of HIV infections diagnosed among MSM were classified as stage 3 (acquired immunodeficiency syndrome), and 75% of MSM with diagnoses of HIV infection were linked to care within 1 month. MSM who were black or African American and MSM aged <25 years were less likely to be linked to care within 1 month of diagnosis of HIV infection compared with other racial/ethnic and age groups.
  • Update to CDC’s U.S. Medical Eligibility Criteria for Contraceptive Use, 2016: Revised Recommendations for the Use of Hormonal Contraception Among Women at High Risk for HIV Infection
    CDC’s U.S. Medical Eligibility Criteria for Contraceptive Use (U.S. MEC) (first published in 2010 and updated in 2016) provides evidence-based guidance for the safe use of contraceptive methods among U.S. women with certain characteristics or medical conditions (1), and is adapted from global guidance from the World Health Organization (WHO) and kept up to date based on continual review of published literature (2). CDC recently evaluated the evidence and the updated WHO guidance on the risk for human immunodeficiency virus (HIV) acquisition among women using hormonal contraception. After careful review, CDC adopted the updated WHO guidance for inclusion in the U.S. MEC guidance; this guidance states that the advantages of progestin-only injectable contraceptive use (including depot medroxyprogesterone acetate [DMPA]) by women at high risk for HIV infection outweigh the theoretical or proven risks (U.S. MEC category 2).
  • QuickStats: Human Immunodeficiency Virus Disease Death Rates Among Women Aged 45–64 Years, by Race and Age Group — National Vital Statistics System, United States, 2000–2015
    Among black women aged 45–54 years, the human immunodeficiency virus (HIV) disease death rate decreased 60% from 28.4 per 100,000 in 2006 to 11.5 in 2015. Among black women aged 55–64 years, the rate increased 42% from 10.0 in 2000 to 14.2 in 2008, before declining to 10.3 in 2015. Among white women aged 45–54 years, the rate decreased 53% from 1.9 in 2005 to 0.9 in 2015. Among white women aged 55–64 years, the rate did not change, remaining at about 0.8. Throughout the period, HIV disease death rates among black women were higher compared with rates among white women for both age groups.
  • HIV Testing Among Transgender Women and Men — 27 States and Guam, 2014–2015
    This analysis of 2014 and 2015 Behavioral Risk Factor Surveillance System data showed that transgender women and men self-reported a lower prevalence of HIV testing (both ever and in the past year) compared with gay and bisexual men whose gender identities match their sex assignments at birth (cisgender). Transgender women and men self-reported testing at levels similar to cisgender heterosexual men and women.
  • Recommendations for HIV Screening of Gay, Bisexual, and Other Men Who Have Sex with Men — United States, 2017
    CDC concludes that the evidence, programmatic experience, and expert opinions are insufficient to warrant changing the current recommendation (annual screening for MSM) to more frequent screening (every 3 or 6 months). Therefore, CDC’s 2006 recommendation for HIV screening of MSM is unchanged; providers in clinical settings should offer HIV screening at least annually to all sexually active MSM. Clinicians can also consider the potential benefits of more frequent HIV screening (e.g., every 3 or 6 months) for some asymptomatic sexually active MSM based on their individual risk factors, local HIV epidemiology, and local policies.
  • Changes in the disparity of HIV diagnosis rates among black women—United States, 2010–2014
    This study suggests that the disparity in HIV diagnosis rates for black women, compared to Hispanic/Latina and white women, may be decreasing, a good sign that targeted prevention efforts are working. However, disparities have not disappeared, and black women continue to have a much higher rate of HIV diagnoses than Hispanic/Latina or white women. CDC remains committed to implementing high-impact prevention approaches that can reduce HIV infections among all blacks.
  • HIV care outcomes among blacks with diagnosed HIV—United States, 2014
    A second MMWR article highlights the need for strong efforts to improve care outcomes among blacks living with HIV. At the end of 2013, only 49% of blacks living with diagnosed HIV had a suppressed viral load—the lowest proportion for any race/ethnicity in the United States. CDC is working with our partners to increase linkage to and retention in care and viral suppression for blacks living with HIV and to address the social determinants of health, such as poverty and discrimination, which contribute to health disparities.
  • Evaluation of the Impact of National HIV Testing Day — United States, 2011–2014
    For approximately 2 decades, June 27th has been designated as National human immunodeficiency virus (HIV) Testing Day (NHTD) to promote HIV testing and increase awareness of the importance of getting tested for HIV.
  • Healthcare Utilization and HIV Testing of Males Aged 15-39 in Physician Offices: 2009-2012
    In 2006, CDC recommended routine HIV testing of adults and adolescents; however, testing coverage in the United States has been suboptimal. Among new HIV diagnoses in 2014, 81% were in males, with the highest number reported in those aged 20–29 years.
  • Cluster of HIV Infections Attributed to Unsafe Injection Practices — Cambodia, December 1, 2014–February 28, 2015
    The largest cluster of new HIV infections ever attributed to unsafe injections among a general population was reported in a rural area of Cambodia; 2.7% of residents were infected. The outbreak was detected after increased demand for HIV testing by residents who perceived themselves to be at risk after exposure to an unlicensed provider of injections and intravenous infusions.
  • HIV-Related Risk Behaviors Among Male High School Students Who Had Sexual Contact with Males — 17 Large Urban School Districts, United States, 2009–2013
    The findings in this report do not provide evidence that HIV-related risk behaviors alone drive the higher numbers of HIV diagnoses among young black MSM compared with young Hispanic and white MSM. In fact, young black male students who had sexual contact with males in this report often had a lower prevalence of HIV-related risk behaviors.
  • Occupational HIV Transmission Among Male Adult Film Performers — Multiple States, 2014
    This is the first well-documented work-related HIV transmission among male adult film performers. A performer was infected by a non–work-related partner who was not aware of his HIV infection. The performer, having tested negative by nucleic acid amplification test within the preceding 14 days, and unaware of his very recent HIV infection, infected another performer and a non–work-related partner. Viruses in all four HIV infections were highly genetically related, indicating a transmission cluster.
  • The HoMBReS and HoMBReS Por un Cambio Interventions to Reduce HIV Disparities Among
    Immigrant Hispanic/Latino Men Hispanics/Latinos in the United States are affected disproportionately by human immunodeficiency virus (HIV) infection, acquired immunodeficiency syndrome (AIDS), and other sexually transmitted diseases (STDs); however, few effective evidence-based prevention interventions for this population exist. This report describes the Hombres Manteniendo Bienestar y Relaciones Saludables (Men Maintaining Wellbeing and Healthy Relationships) (HoMBReS) intervention, which was developed by a community-based, participatory research partnership in North Carolina and initially implemented during 2005–2009.
TOP